Company page

Celyad Oncology Sa

Celyad Oncology SA is a public company based in Belgium, specializing in innovative cancer therapies. The company is listed under the ticker CYAD and has a market capitalization of approximately €13.69 million. Celyad focuses on developing advanced treatments to improve patient outcomes in oncology.

profileCYAD:EURONEXTAI content: aiUpdated June 24, 2026/company/celyad-oncology-sa/c-upevywda
Celyad Oncology Sa logo
Ticker
CYAD:EURONEXT
Asset type
Stock
Market cap
$13.7M
Sector
Health Technology
Industry
Biotechnology
Exchange
EURONEXT
Currency
EUR